Advisor OS LLC Sells 149 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Advisor OS LLC lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.4% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,246 shares of the healthcare conglomerate’s stock after selling 149 shares during the period. Advisor OS LLC’s holdings in UnitedHealth Group were worth $1,653,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the business. Sustainable Insight Capital Management LLC raised its stake in UnitedHealth Group by 3.3% in the 2nd quarter. Sustainable Insight Capital Management LLC now owns 781 shares of the healthcare conglomerate’s stock valued at $398,000 after acquiring an additional 25 shares during the period. Candriam S.C.A. raised its stake in UnitedHealth Group by 14.8% in the 2nd quarter. Candriam S.C.A. now owns 450,366 shares of the healthcare conglomerate’s stock valued at $229,343,000 after acquiring an additional 58,014 shares during the period. North Star Asset Management Inc. grew its holdings in UnitedHealth Group by 14.8% in the 2nd quarter. North Star Asset Management Inc. now owns 22,753 shares of the healthcare conglomerate’s stock valued at $11,587,000 after buying an additional 2,938 shares in the last quarter. Private Advisor Group LLC grew its holdings in UnitedHealth Group by 13.6% in the 2nd quarter. Private Advisor Group LLC now owns 68,705 shares of the healthcare conglomerate’s stock valued at $34,989,000 after buying an additional 8,204 shares in the last quarter. Finally, New York Life Investment Management LLC grew its holdings in UnitedHealth Group by 0.5% in the 2nd quarter. New York Life Investment Management LLC now owns 141,339 shares of the healthcare conglomerate’s stock valued at $71,978,000 after buying an additional 769 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling

In related news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $597.64 on Friday. The stock’s 50 day moving average is $558.98 and its 200 day moving average is $515.15. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. The firm has a market cap of $551.87 billion, a P/E ratio of 36.53, a P/E/G ratio of 1.68 and a beta of 0.58. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $607.94.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.66 by $0.14. The firm had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company’s revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $6.14 earnings per share. As a group, research analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a dividend of $2.10 per share. The ex-dividend date is Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.41%. UnitedHealth Group’s dividend payout ratio is 51.34%.

Wall Street Analyst Weigh In

A number of brokerages have commented on UNH. Argus upped their price objective on UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Baird R W raised UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. UBS Group raised their price target on UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research report on Thursday, July 18th. JPMorgan Chase & Co. raised their price target on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research report on Thursday, May 30th. Finally, Royal Bank of Canada raised their price target on UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. One analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $614.17.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.